type here...

CATEGORIES

Clinical Trials

LATEST

123Page 1 of 3

TRENDING

EDITORS CHOICE

Colchicine Shows 48% Reduction in Future Cardio Issues for Heart Attack Victims

Medika Life -
Early, in-hospital treatment with colchicine reduces the odds of future cardiovascular problems by 48% in people who have just survived a heart attack

Covid’s Elephant in the Room. We Must Address it

Robert Turner, Founding Editor -
This article is based on probability, rather than certainty. The author is of the opinion that at some point the two terms become interchangeable....

First NASH Patient Dosed with CRV431 in Phase 2 ‘AMBITION’ Clinical Trial

Medika Life -
The ‘AMBITION' trial, is designed to assess safety, tolerability, and pharmacokinetics of 75 mg CRV431, administered orally to F2 and F3 NASH patients

Texas: Vaccine Clinical Study Participants – Men and Women

Medika Life -
Apply to Cedar Health to participate in a clinical vaccine study This study is open to healthy men and women. Vaccine safety and it's impact

CONNECT WITH US ON SOCIAL MEDIA

Medika Life is a unique, not-for-profit operating unit of FINN Partners and maintains an independent voice. Authors opinions may not necessarily represent those shared by FINN Partners and content cannot be promotional - rather informational centered on health issues, life science innovation, ecohealth and patient experience.

© Medika Life 2020 - 2022

Compliance

CORPORATE & MEDIA

Popular categories